Leukemia vs Lymphoma

What is the difference between leukemia and lymphoma?

It's a question that confuses even medical professionals, largely because the definitions are constantly changing.

Lymphoma vs Leukemia

In a very broad sense, lymphomas and leukemias describe cancers that derive from blood-borne cells.

To that end, it used to be easier to understand the difference between leukemia, lymphoma and solid tumor cancers because, simply put, it was thought that blood cancers don't develop solid tumors. However, several subtypes of lymphoma are capable of developing solid tumors, nullifying this easy classification.

Also, there is the question of the type of blood-borne cell in which the cancer originated.

For starters, if a cancer derives from a lymphoid cell—-this includes lymphoblasts, lymphocytes, immunoblasts, plasma cells, follicle center cells-—then it should first be called a Lymphoid neoplasm. This is a relatively new term adopted by the latest edition of the American Joint Committee on Cancer (AJCC), the final word on cancer terminology and staging.

If it is indeed a Lymphoid Neoplasm, then a few other determinations are to be made based on how the cancer presents itself:

  • Does the cancer affect circulating blood cells only? Leukemia.
  • Does the cancer also produce tumor masses? Lymphoma.
  • Does the cancer affect circulating blood cells AND produce tumor mass? Lymphoma/leukemia.

Leukemia vs Lymphoma: The future of the terminology

There are many reasons that are emerging in research and clinical trials across the world that suggest that there is no de facto difference between a lymphoma and leukemia—rather, they are merely two different phases of the very same developing disease.

Related Reading

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap